Low molecular weight heparins: Are they interchangeable? Yes

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 1, 2003, Pages 10-11

  Prandoni, P ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

CHEMISTRY; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; NOTE; THROMBOEMBOLISM;

ANTICOAGULANTS; CLINICAL TRIALS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; THROMBOEMBOLISM; THROMBOLYTIC THERAPY;

EID: 0141818981     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00014.x     Document Type: Note

References (10)

1. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-98.
2. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman M, Dalen JE. Heparin and lowmolecular-weight heparin. mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (Suppl.): 64-94.
3. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000; 160: 181-8.
4. Geerts WH, Heit JH, Clagett GP, Pineo GF, Colwell CW, Anderson FA, Wheeler HB. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl.): 132-75.
5. Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000; 355: 1936-42.
6. Lopez LM. Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism. Pharmacotherapy 2001; 21: 56S-61S.
7. Hull RD, Raskob GL, Pineo GF, Green D, Trowbridge AA, Elliott CG, Lerner RG, Hall J, Sparling T, Brettell JN, Carter CJ, George R, Merli G, Ward J, Mayo W, Rosenbloom D, Brant R. Subcutaneous low molecular-weight heparin compared with intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326: 975-82.
8. Planès A, Samama MM, Lensing AWA, Büller HR, Barre J, Vochelle N, Beau B,. Prevention of deep vein thrombosis after hip replacement. Thromb Haemost 1999; 81: 22-5.
9. Planès A. An equivalence study of two low-molecular-weight heparins in the prevention and treatment of deep-vein thrombosis after total hip replacement. Semin Thromb Hemost 2000; 26 (Suppl. 1): 57-60.
10. Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11b-ESSENCE Meta-Anal Circulation 1999; 100: 1602-8.